- Home
- KAR vs PRAX Comparison
KAR vs PRAX Comparison
Compare KAR & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KAR
- PRAX
- Stock Information
- Founded
- KAR 2006
- PRAX 2015
- Country
- KAR United States
- PRAX United States
- Employees
- KAR N/A
- PRAX N/A
- Industry
- KAR Retail-Auto Dealers and Gas Stations
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- KAR Consumer Discretionary
- PRAX Health Care
- Exchange
- KAR Nasdaq
- PRAX Nasdaq
- Market Cap
- KAR 1.9B
- PRAX 1.5B
- IPO Year
- KAR 2009
- PRAX 2020
- Fundamental
- Price
- KAR $20.00
- PRAX $69.06
- Analyst Decision
- KAR Buy
- PRAX Strong Buy
- Analyst Count
- KAR 4
- PRAX 9
- Target Price
- KAR $22.00
- PRAX $146.33
- AVG Volume (30 Days)
- KAR 646.3K
- PRAX 355.4K
- Earning Date
- KAR 11-06-2024
- PRAX 11-06-2024
- Dividend Yield
- KAR N/A
- PRAX N/A
- EPS Growth
- KAR N/A
- PRAX N/A
- EPS
- KAR 0.19
- PRAX N/A
- Revenue
- KAR $1,687,800,000.00
- PRAX $1,605,000.00
- Revenue This Year
- KAR $5.10
- PRAX N/A
- Revenue Next Year
- KAR $3.82
- PRAX N/A
- P/E Ratio
- KAR $110.53
- PRAX N/A
- Revenue Growth
- KAR 3.76
- PRAX N/A
- 52 Week Low
- KAR $12.86
- PRAX $16.46
- 52 Week High
- KAR $20.85
- PRAX $86.93
- Technical
- Relative Strength Index (RSI)
- KAR 53.85
- PRAX 50.90
- Support Level
- KAR $20.37
- PRAX $70.03
- Resistance Level
- KAR $20.85
- PRAX $73.49
- Average True Range (ATR)
- KAR 0.46
- PRAX 4.10
- MACD
- KAR -0.13
- PRAX -0.17
- Stochastic Oscillator
- KAR 23.08
- PRAX 48.89
About KAR OPENLANE Inc.
Openlane Inc offers a digital marketplace for used vehicles. The services comprise financing, repossessions, repairs, transportation, warranty, and inventory services. It operates used-vehicle auctions and offers complete online services for all parties involved. The company has two operating segments which include Marketplace and Finance, of which it generates the majority of the revenue from the Marketplace segment.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.